First-Line Treatment of HER2-Positive Metastatic Breast Cancer

preview_player
Показать описание
The panelists, Adam M. Brufsky, MD; Sara A. Hurvitz, MD; Hope S. Rugo, MD; Joyce A. O’Shaughnessy, MD; and Christy A. Russell, MD, outline first-line treatment options in HER2-positive metastatic breast cancer.
  1. OncLive
  2. cancer
  3. oncology
Рекомендации по теме
First-Line Treatment of 0:06:08

First-Line Treatment of HER2-Positive Metastatic Breast Cancer

First-Line Treatment of 0:08:40

First-Line Treatment of HER2-Positive Metastatic Breast Cancer

Identifying drivers of 0:02:24

Identifying drivers of first-line HR+/HER2- metastatic breast cancer treatment choices

Medical update: HER2-Positive 0:51:38

Medical update: HER2-Positive and triple-positive metastatic breast cancer

Sequencing Treatment Options 0:02:43

Sequencing Treatment Options in HER2 Positive Breast Cancer: 2023 Best of Breast Conference

Combination Treatment of 0:06:40

Combination Treatment of HER2+ Metastatic Breast Cancer: First-Line Therapy

Management of HER2 0:04:01

Management of HER2 positive metastatic breast cancer treatment algorithm

Treatment strategies for 0:02:15

Treatment strategies for HER2+ metastatic breast cancer

First-line Therapy for 0:07:34

First-line Therapy for HR-positive, HER2-negative, mBC

First-line camizestrant for 0:00:52

First-line camizestrant for ER+/HER2- advanced breast cancer

Treatment Updated for 0:30:57

Treatment Updated for HER2 Positive Breast Cancer: Changing Paradigms

The evolution of 0:02:09

The evolution of HER2 targeting in metastatic breast breast cancer

First-Line ER-Positive Metastatic 0:05:32

First-Line ER-Positive Metastatic Breast Cancer Treatments

Treatment for HER2+ 0:01:39

Treatment for HER2+ metastatic breast cancer

HER2+ Breast Cancer: 0:03:44

HER2+ Breast Cancer: Brain Metastasis Prevalence & Later-Line Therapy

Current Treatment Options 0:01:31

Current Treatment Options for Patients With HER2-Positive Metastatic Breast Cancer

Treatment Options in 0:06:46

Treatment Options in HER2+ Metastatic Breast Cancer

Study of Targeted 0:03:19

Study of Targeted Therapy for HER2-Positive Metastatic Breast Cancer

Frontline T-DM1 in 0:03:58

Frontline T-DM1 in HER2-Positive Metastatic Breast Cancer

Frontline Pertuzumab for 0:06:00

Frontline Pertuzumab for Metastatic Breast Cancer

Dr Bardia on 0:01:27

Dr Bardia on Current Approaches to HER2+ Breast Cancer Management

Combination Treatment of 0:06:46

Combination Treatment of HER2+ Metastatic Breast Cancer: First-Line Therapy

Optimizing Therapy in 0:47:29

Optimizing Therapy in HER2+ Disease with Dr. Reshma Mahtani

Poziotinib for HER2-positive 0:01:29

Poziotinib for HER2-positive metastatic breast cancer

Комментарии
Автор

Why faslodex injection treatment used for prostate cancer, I wonder.

hhwe
Автор

After taking everolimus 5mg for 2wks if stomstitis occur when it will reduce

kishorepokala